SCHEMBL114529

SCHEMBL114529

CCCCCCOCC(CO)OCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.61
LPAR1 Q92633 7/20 0.50
LPAR3 Q9UBY5 7/20 0.50
LPAR2 Q9HBW0 4/20 0.50
HTT P42858 2/20 0.50
MEN1 O00255 1/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.48
LPAR6 P43657 3/20 0.47
LPAR4 Q99677 3/20 0.47
LPAR5 Q9H1C0 3/20 0.47
SPHK1 Q9NYA1 1/20 0.46
ALDH1A1 P00352 1/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
PRKD3 O94806 1/20 0.45
PRKCG P05129 1/20 0.45
PRKCB P05771 1/20 0.45
PRKCA P17252 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8912520 1.00 USP2 (0.61) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL16301540 1.00 USP2 (0.61) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL10831346 1.00 USP2 (0.61) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL5765877 0.92 USP2 (0.50) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL25266425 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL7060157 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL15016340 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL103054 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL7063456 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL7063486 0.90 USP2 (0.63) USP2LPAR1LPAR3LPAR2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026102188-A1 NANOPARTICLE NAD+ FORMULATIONS AND RELATED METHODS MOLECULAR WORLD HEALTH, INC. (US) 2026-05-15 WO claimed
US-20260071379-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING SYMRISE AG (DE) 2026-03-12 US claimed
US-20260071145-A1 DETERGENTS AND CLEANING COMPOSITIONS WITH IMPROVED ANTI-REDEPOSITION PROPERTIES SYMRISE AG (DE) 2026-03-12 US claimed
US-20260071144-A1 DETERGENTS WITH IMPROVED DYE TRANSFER INHIBITION SYMRISE AG (DE) 2026-03-12 US claimed
US-20260071146-A1 DISH CLEANING AND/OR DISH RINSING COMPOSITION WITH IMPROVED FINISHING PROPERTIES SYMRISE AG (DE) 2026-03-12 US claimed
EP-4231992-B1 ANHYDROUS ALCOHOL-FREE SILKY FRAGRANCE FORMULATION AKI INC (US) 2026-03-04 EP claimed
EP-4608945-A1 DETERGENTS AND CLEANING COMPOSITIONS WITH IMPROVED ANTI-REDEPOSITION PROPERTIES Symrise AG (DE) 2025-09-03 EP claimed
EP-4608949-A2 DETERGENTS AND CLEANING COMPOSITIONS WITH STABILIZED ENZYME Symrise AG (DE) 2025-09-03 EP claimed
EP-4608951-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING Symrise AG (DE) 2025-09-03 EP claimed
EP-4608953-A1 DISH CLEANING AND/OR DISH RINSING COMPOSITION WITH IMPROVED FINISHING PROPERTIES Symrise AG (DE) 2025-09-03 EP claimed
WO-2015063471-A1 STABILISED MULTIPLE EMULSIONS AS SKIN PROTECTION PRODUCT DEB IP LIMITED (GB) 2015-05-07 WO claimed
EP-2773334-A2 COMPOSITION WITH SUSTAINED ANTIMICROBIAL ACTIVITY The Trustees of Columbia University in the City of New York (US) 2014-09-10 EP claimed
US-20140243417-A1 Composition with Sustained Antimicrobial Activity UNIV COLUMBIA (US) 2014-08-28 US claimed
US-8716506-B2 Xylitol esters and ethers applied as alternative emulsifiers, solvents, co-emulsifiers and preservative systems for pharmaceutical and cosmetic products CHEMYUNION QUIMICA LTDA. (BR) 2014-05-06 US claimed
WO-2013067150-A2 COMPOSITION WITH SUSTAINED ANTIMICROBIAL ACTIVITY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-05-10 WO claimed
EP-2200432-A2 ANTIMICROBIAL COMPOSITION THAT CAN BE USED IN COSMETICS AND IN DERMATOLOGY Laboratoire Nuxe (FR) 2010-06-30 EP claimed
WO-2009071776-A2 ANTIMICROBIAL COMPOSITION THAT CAN BE USED IN COSMETICS AND IN DERMATOLOGY LABORATOIRE NUXE (FR) 2009-06-11 WO claimed
US-6835374-B2 Fine particle size; mixing, suspension active material with surfactant REHEIS, INC. 2004-12-28 US claimed
EP-1417953-A2 Novel antiperspirant/deodorant active for no white residue sticks and soft solids REHEIS, INC. (US) 2004-05-12 EP claimed
US-20040081632-A1 Novel antiperspirant/deodorant active for no white residue sticks and soft solids SUMMIT RESEARCH LABS, INC. 2004-04-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071144-A1 DETERGENTS WITH IMPROVED DYE TRANSFER INHIBITION HSD17B1, HSDL2, HSD17B3 USP2 784/4885LPAR1 3714/4885LPAR3 2922/4885
US-20260071379-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING PON1, ACHE, TPSB2 USP2 1038/4885LPAR1 3854/4885LPAR3 3925/4885
US-20260071146-A1 DISH CLEANING AND/OR DISH RINSING COMPOSITION WITH IMPROVED FINISHING PROPERTIES CYP51A1, HSD17B1, HSD3B1 USP2 415/4885LPAR1 2910/4885LPAR3 2654/4885
US-20260071145-A1 DETERGENTS AND CLEANING COMPOSITIONS WITH IMPROVED ANTI-REDEPOSITION PROPERTIES CYP51A1, HSD17B1, HSD3B1 USP2 133/4885LPAR1 1809/4885LPAR3 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.